Un modelo asistencial para pacientes ancianos y pobres con cánceres, en la India Dear Editor: India leads the world in the number of cases of oral and throat cancer. Moreover, 900,000 people are diagnosed with cancer each year and 50% of them are destined to die within the fi rst year 1 . This letter presents new data on how a nonprofi t center called the Kailash Cancer Hospital in India (Goraj, Gujarat State) provides cost-effective cancer treatment for the poor people. The model presented here has the potential to be replicated in other developing nations.A total of 81 patients (54% females) were treated for cancer from January 2008 to August 2009. More patients came from towns (55.6%) than villages (44.4%) showing increased awareness in urban areas. The patients' occupation included farming (27.2%), followed by homemaking (21.0%), daily abor in construction jobs (14.8%), factory working (14.8%), unemployed (8.6%), retired (3.7) and miscellaneous (driver, maid, tailor, priest, etc; 9.9%). The mean age of the 81 patients was 53.7 ± 5.0 years (range 50-71, 81.5% aged between 50 to 59 years, 16.1% aged between 60 to 69 years and 2.4% over 70 years).The average cost of treatment was USD 582.7 ± 231.7, (range 177.1-1458.3), which is four times cheaper than other hospitals. There were no gender differences in costs. Radiotherapy was the form of treatment mostly used (77.8%) followed by surgery (12.3%) and chemotherapy (9.9%). The original bill and actual amount paid by patients differed signifi cantly (Kruskal-Wallis test, p < 0.05) among the three treatment types and the poor received signifi cant discounts for treatment (Figure 1).Radiotherapy was the most expensive form of treatment, (USD 608.1 ± 208.8 n = 63), which was 1.6 times the cost of chemotherapy (USD 382.8 ± 180.2, n = 8,). Patients paid the highest amounts for radiotherapy (USD 404.6 ± 195.4, n = 63), representing nearly 1.4-1.9 times of the costs of surgery and chemotherapy (Figure 1). The differences of total costs and the actual amount paid, were signifi cantly different between radiotherapy and chemotherapy (Wilcoxon rank test, P < 0.01).